CRWV snapped back 5.8% on the week to close at CAD 16.86 — a sharp reversal from the 7% slide flagged in last week's note — yet the data points underneath the surface paint a more complicated picture than a simple recovery.
The most meaningful shift this week is in short positioning, and it tells a genuinely encouraging story for bulls. Short interest dropped 20% in a single session on September 7, pulling the 30-day trend firmly negative at -13%. The absolute share count has collapsed from a recent peak of around 157,000 shares borrowed in early September to roughly 96,400 — a retreat that coincides neatly with the price bounce and suggests shorts are covering rather than adding. Borrowing costs have eased in parallel, falling 37% over the week to 3.45%, after briefly spiking above 5% through the final days of August. That mid-week spike — which ran from roughly 5.4% on August 31 to under 3.5% now — looks like a short-covering scramble that has largely played out. The ORTEX short score sits at 28.0, ranking in just the 12th percentile of the universe, which means the short-side pressure on this name is considerably lower than most peers. Positioning looks lighter rather than crowded.
The momentum and earnings backdrop supports the stock's renewed footing. CRWV jumped 22% the day after its August 11 results — the largest single-session earnings reaction in its recent history — and held most of that gain over the following five days. The next earnings event is pencilled in for November 11, giving the stock roughly ten weeks before the market gets another fundamental read. Forward earnings revisions remain aggressive: the EPS 12-month forward year-on-year increase factor scores in the 50th percentile universe-wide, but a reported growth figure of close to 195% underpins the momentum scores (30-day EPS momentum in the 82nd percentile, 90-day in the 86th). Valuation multiples are stale — the only available EV figure reflects a December 2025 balance sheet — so the Street's current implied upside cannot be reconciled against a clean multiple with confidence.
The institutional picture carries the most interesting tension. BlackRock added nearly 14.7 million shares as of August 31, more than doubling its position — a significant accumulation from one of the world's largest passive and active managers. Vanguard entities added a combined 8 million shares over recent quarters. Those inflows sit alongside an awkward counter-signal: CEO Michael Intrator, flagged in last week's note as having sold roughly $27 million under a 10b5-1 plan in late August, remains the largest holder at 9.5% of shares but trimmed 2.8 million shares in the most recently reported period. Fellow insiders Brannin McBee and Brian Venturo both reduced positions as well. All sales appear plan-driven rather than discretionary, which limits their signalling value — but the 90-day insider net remains firmly negative, and no open-market purchases have appeared in the recent record to balance the picture.
What to watch next: the tension between institutional accumulation by major passive managers and continued insider reduction under pre-arranged plans is the defining feature of this setup heading toward the November print — whether that divergence narrows or widens will say a great deal about where conviction actually lies.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
